bamlanivimab
adintrevimab
SARS-CoV-2
novel coronavirus pneumonia
2019-nCoV acute respiratory disease
coronavirus disease 2019
corona
coronavirus
Wuhan virus
COVID-19
Wuhan coronavirus
Wuhan flu
Wuhan pneumonia
deltacron
anticorrelate
China virus
Chinese virus
patritumab
mapatumumab
zanolimumab
sonepcizumab
tucotuzumab
guselkumab
elotuzumab
immunocompatible
panitumumab
naptumomab estafenatox
dacetuzumab
amlitelimab
oleclumab
antimonoclonal
conatumumab
onartuzumab
cibisatamab
antiantibody
properdin
antipeptide
Theta variant
drozitumab
muromonab
agonistic monoclonal antibody
intetumumab
immunopeptide
vobarilizumab
radioimmunoreactivity
seroblock
ozogamicin
Zeta variant
bivatuzumab
tislelizumab